Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
It reduces pro-inflammatory cytokines and has shown anti-colitis effects in mouse models (Kannengiesser et al., Inflammatory Bowel Diseases, 2008)
Presented for research literature review only Dadzie OE (2016)
Katarzyna Otulak-Kozie, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
March 13 Product: Mirums Livmarli Indication: Cholestatic pruritus in PFIC California-based Mirum Pharmaceuticals secured the FDAs approval for Livmarli for the oral treatment of cholestatic pruritus in patients five years and older with progressive familial intrahepatic cholestasis (PFIC), a rare genetic disorder that causes progressive liver disease
US$ 22.15
US$ 26.36
US$ 20.99
US$ 28.29
US$ 21.15
US$ 23.30
US$ 28.52
